{
  "folder": "IC-325",
  "content": "{{knowledge objective\n|Identifiant=OIC-325-02-A\n|Item_parent=Identification and management of risks associated with medicines and biomaterials, iatrogenic risk, medicinal errors (see items 4 and 5)\n|Item_parent_short=Identification and management of risks associated with medicines and biomaterials, iatrogenic risk, medication errors (see items 4 and 5)\n|Rank=A\n|Title=Understand the issues concerning the risks associated with medicines and biomaterials.\n|Description=None\n|Section=Definition\n|Contributors=Marie Briet\n|Order=2}}\n\n== There are two types of risk associated with medicines ==\n\n=== Individual issues: ===\n\n* at patient level to ensure proper use of medicines and appropriate management.\n\n=== Public health issues: ===\n\n* The need for a system for monitoring, detecting and analysing signals in real life\n* To fine-tune information and regulatory decisions relating to medicines\n\n<br /><br />",
  "question": {
    "question": "Which of the following best describes the 'public health issues' related to the risks associated with medicines?",
    "option_a": "Ensuring individual patients use medicines correctly and safely",
    "option_b": "Monitoring and analyzing signals in real life to inform regulatory decisions",
    "option_c": "Managing individual patient data for personalized treatment plans",
    "option_d": "Developing new medicines to replace those with known risks",
    "correct_option": "B"
  }
}